Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing in privately insured women with surgically treated breast cancer.

Breast cancer research and treatment - 1 Feb 2023

Dinan Michaela A, Pitafi Sarah, Greenup Rachel A, Long Jessica B, Gross Cary P

Abstract excerpt

PURPOSE: Rates of BRCA1 and BRCA2 prevalence among women with breast cancer vary by age, hormone receptor status, and family history. Recommendations for genetic testing have varied between overlapping guidelines, payor coverage policies, and have evolved over time, resulting in unclear implications for adoption into routine breast cancer care. METHODS: Using a large, private insurer database, we examined rates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA1

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Insurance, Health

Source

Identifiers

PMID: 36542252
DOI: 10.1007/s10549-022-06829-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing in privately insured women with surgically treated breast cancer.PMID 36542252Read ↗

Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.Semantic proximity Read ↗

Genetic testing in women with breast cancer: implications for treatment.Semantic proximity Read ↗

BRCA testing utilization among commercially insured women with breast or ovarian cancer.Semantic proximity Read ↗

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.Semantic proximity Read ↗

The Role of Genetic Testing in Patients With Breast Cancer: A Review.Semantic proximity Read ↗

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.Semantic proximity Read ↗

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read ↗

Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.Semantic proximity Read ↗

Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.Semantic proximity Read ↗

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast CancerSemantic proximity Read ↗

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.Semantic proximity Read ↗

Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.